Research and Markets: Biochips - Technologies, Markets and Companies Report

The report starts with a description of technologies as a basis for estimation of markets. Technologies and areas of applications include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, protein microarrays, RNA splice variants, and microRNA. Areas of application such as point-of-care, genetic screening, cancer, and diagnosis of infections are included. Biochips/microarrays will play an important role in the development of personalized medicine.

The report provides current share of each segment: market size in 2009 and projected value for the years 2014 and 2019. Gene expression has the largest share and is an established market. Share of microarray technologies in other areas will grow with the maximum growth in RNA splice variants followed by epigenetics. The growth in protein microarrays is somewhat less, partly because it is more mature than the other submarkets and has already shown considerable growth in the past. Impact of next generation sequencing on segments of microarray markets is identified. Customer requirements and unmet needs are described. Markets are also analyzed according to geographical areas.

Brief profiles of companies involved in biochip/microarray technologies are provided. Currently selected 53 companies are included along with listing of 65 collaborations between companies. The text is supplemented by 15 tables, 6 figures and 100 references to literature.